Methods of diagnosing renal tumors by determining the expression level of RNA encoding the HGPRBMY18 polypeptide
AssigneeBristol-Myers Squibb Company
InventorsJohn N. Feder, Gabriel Mintier, Chandra S. Ramanathan
Life of this patent
Estimating the term…
Abstract
The present invention describes a newly discovered human G-protein coupled receptor and its encoding polynucleotide. Also described are expression vectors, host cells, agonists, antagonists, antisense molecules, and antibodies associated with the polynucleotide and/or polypeptide of the present invention. In addition, methods for treating, diagnosing, preventing, and screening for disorders associated with aberrant cell growth, endocrine conditions, neurological conditions, and diseases or disorders related to the pituitary gland, colon, breast, lungs, kidney, and prostate are illustrated.
Claims2
A method of diagnosing renal tumors comprising:
- a) determining the expression level of RNA encoding a polypeptide comprising the sequence of amino acids 2 of 361 of SEQ ID NO:2 in a normal kidney sample by measuring RNA of said polypeptide;
- and
- b) comparing said expression level of said RNA from a kidney test sample;
- wherein an elevated expression level of said RNA in said test sample relative to the expression level of said RNA in said normal sample is indicative of renal tumors-or a predisposition to renal tumors.
Dependencies are inferred from the claim text.